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Abstract
Background: Research activities in sub-Saharan Africa may be limited to delegated tasks due to the strong control
from Western collaborators, which could lead to scientific production of little value in terms of its impact on social
and economic innovation in less developed areas. However, the current contexts of international biomedical
research including the development of public-private partnerships and research institutions in Africa suggest that
scientific activities are growing in sub-Saharan Africa. This study aims to describe the patterns of clinical research
activities at a sub-Saharan biomedical research center.
Methods: In-depth interviews were conducted with a core group of researchers at the Medical Research Unit of
the Albert Schweitzer Hospital from June 2009 to February 2010 in Lambaréné, Gabon. Scientific activities running
at the MRU as well as the implementation of ethical and regulatory standards were covered by the interview
sessions.
Results: The framework of clinical research includes transnational studies and research initiated locally. In
transnational collaborations, a sub-Saharan research institution may be limited to producing confirmatory and late-
stage data with little impact on economic and social innovation. However, ethical and regulatory guidelines are
being implemented taking into consideration the local contexts. Similarly, the scientific content of studies designed
by researchers at the MRU, if local needs are taken into account, may potentially contribute to a scientific
production with long-term value on social and economic innovation in sub-Saharan Africa.
Conclusion: Further research questions and methods in social sciences should comprehensively address the
construction of scientific content with the social, economic and cultural contexts surrounding research activities.
Background
Scientific production all over the world follows the pat-
tern of core-periphery relationships in which the contri-
bution of the periphery, including developing regions like
sub-Saharan Africa, is marginal and depends on structure
and infrastructure accessible through collaborative pro-
jects lead by institutions and scientists from core regions
in Western Europe and North America. Thus, some
authors assume that the practice of science in Africa
would provide subsidiary sets of data to strengthen insti-
tutions, production and social value in the more devel-
oped world and would conversely generate research of
only limited generalization and of little impact on the
economic and social development of the local commu-
nities in peripheral regions [1-3].
So far, numerous studies addressed the questions
related to the contribution of peripheral regions to
worldwide scientific production. However, most of them
use quantitative approaches as dominant methods target-
ing researchers in the frame of collaborative projects and
assess internationally indexed databases. Overall, the
results state that the works of African scientists regis-
tered in indexed databases are collaborative publications,
b u tt h e yp a l ei nc o m p a r i s o nt ot h er e s to ft h ew o r l di n
terms of proportion and notoriety [4,5]. Additionally, a
corpus of knowledge is generated with little potential for
innovation and thus of poor social and economic value
[5-7]. All these characteristics call an auxiliary type of
scientific production to mind and may have prevented
social scientists from focusing on scientific production in
sub-Saharan Africa as a complex process with its own
structures of centralization. However, numerous biome-
dical research institutions with a growing number of
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local, regional and international partners, which suggests
t h a ts c i e n c ei sa c t i v ei nt h e s ea r e a s .I nt h i sp a p e rw e
describe the patterns of clinical research activities under-
lined by perceptions of scientists working in a “periph-
eral” research center in the sub-Saharan Africa region of
Lambaréné, Gabon.
Methods
Study site
The first major stage in the development of the Medical
Research Unit (MRU) of the Albert Schweitzer Hospital
(HAS) lasted from its creation in 1981 to the end of the
eighties. Since 1992, the site has succeeded in broadening
its research activities to cover about 35,000 inhabitants
living in the poor socio-economic conditions of the main
town in Lambaréné and in the villages along the national
road number 1 of Gabon.
Within a short period of time, a core group of research-
ers who live in Lambaréné and work permanently for the
MRU has emerged. The core group of scientists interact
with main collaborators from the German research insti-
t u t ea n du n i v e r s i t ya sw e l la sf r o mn u m e r o u sn a t i o n a l ,
regional and international networks [8].
Study participants
Members of the core research staff including investigators
and field workers were asked to participate in the in-depth
interview sessions. Interviews were conducted from June
2009 to February 2010. The following criteria were consid-
ered for the enrolment in the interview sessions. Research
members who are experienced in the conduct of New
Investigational Product Trials (NIP) and/or basic research,
have regular interactions with research participants
through study information, informed consent and/or clini-
cal procedures and have a permanent position or intend
to pursue a career as researcher or worker in the field of
clinical research at the MRU were included in our study.
The scope and the conduct of in-depth interviews
The scientific interests of the MRU focus on clinical trials
in which novel drug combinations and vaccines against
infectious diseases are being developed. Fundamental
sciences such as molecular biology and immunology,
which investigate the pathogenesis of infectious diseases
are interest as well [8]. In order to succeed, the site has
developed opportunities for international grant applica-
tions and is engaged in numerous public-private partner-
ships in which multicenter and transnational drug and
vaccine trials are being conducted in Lambaréné. More-
over, the MRU has maintained close collaborations with
institutions and scientists from Germany, the Nether-
lands and the United Kingdom. Therefore, it is likely that
the MRU is dependent on the knowledge and abilities of
scientists from wealthy core countries with regard to
infrastructure and funding, suggesting that the patterns
of core-periphery relationships may apply to the research
being conducted at the MRU. The discussion about the
abilities of MRU core researchers and the determinants
that influence the conduct of clinical research in the
social, economic and cultural contexts of Lambaréné was
expected to support the understanding of how the scien-
tific work is generated and perceived by the producers in
a context of periphery dealing with core collaborators
based in rich countries. Then, we postulated the interac-
tions and relationships between scientists and research
participants as essential in establishing science in the
local contexts of Lambaréné and targeted the information
procedures including the realization of informed consent
and perception by scientists of the local communities’
responses to research activities. The focus on informed
consent as a transnational and relational procedure
allowed us to discuss its production at transnational and
local levels as well as ethical standards as part of the
whole process of biomedical science production.
The interview sessions were semi open; the intervie-
wees’ speech was the focus, although the interviewer
was able to direct on the main topics of the in-depth
interview guide used to conduct the sessions. Interviews
sessions were conducted in French, recorded, and tran-
scribed for content analysis with regard to the interview
guide.
Results
Characteristics of interviewees and patterns of clinical
research
At the time the interview sessions took place, there were
26 people at the MRU whose job description was related
to research including clinical, laboratory and field-based
procedures. They were biologists, clinicians, nurses and
field workers. Based on the administrative file of the
MRU and the informal discussion with site directors, 12
fulfilled our main selection criteria (Table 1). Following
the interviews analysis, scientific framework and local
contexts surrounding clinical research activities were
identified as the main patterns of the biomedical
research at the MRU (Table 2)
The framework of clinical research
Transnational research
Transnational studies are the most important part of
research activities at the Medical Research Unit. The
structure of typical transnational research conducted at
the MRU includes partnerships and relationships between
sponsor, research institutions, scientists in Europe and/or
North America and the MRU and its scientists in techni-
cally and socio-economically poor conditions of a sub-
Saharan Africa country. For instance, the MRU together
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and Kenya is evaluating antimalarial drugs as an intermit-
tent preventive strategy against malaria in pregnant
women on the field. The European partners are two
research institutions that are coordinating scientific, tech-
nical and financial aspects of the project. The European
Developing Countries Trials Partnership (EDCTP), a spe-
cialized funding organism of the European Union, funds
the project.
In a similar framework of a malaria vaccine trial, a
young investigator describes the scope of her work at the
MRU: “Our work on the field consists of vaccination, fol-
low-up visits and also to ensure that the data collected
are accurate and can be well analyzed and interpreted”.
Scientists of the MRU, however, may not be restricted
to executing field procedures. They can contribute, for
instance, to amending the study protocol and design, a
more substantial scientific contribution that later
impacts the field procedures, although any amendment
should be done according to the rules defined by or
with collaborators: “Most of time, the sponsor comes with
the study protocol already done. If there are scientific,
medical or ethical concerns that are pointed out by us,
we have to agree on changes to the protocol with the
sponsor”. But, the process of protocol amendment seems
very well “structured, the study protocol is written in
Europe, in the Netherlands for instance, for a multicenter
study purpose. Modification and amendment to this pro-
tocol cannot be based on our willing without a green
light from our collaborators”.
Academic or ancillary research
There is an opportunity for studies at the MRU that most
of investigators call academic research. Academic research
is either an investigator-based initiative of the MRU or an
ancillary study to ongoing transnational research. Both are
described as MRU’s own research especially in terms of
cognitive as well as operational contributions. The study
idea, design, advocacy within the group, informed consent
information, study conduct, data collection, analysis and
publication are all carried out within the MRU group.
Academic research is perceived as a source of scientific
value and personal satisfaction as well as opportunity for
career development, although investigators did not clearly
state that transnational research is less valuable on an
Table 1 Characteristics of study participants
Study
Identity
Duration at
MRU (year)
Sex Age Position Status Interviews Experience
with
research
INV1 5 M 33 Investigator Middle X* PPP, AC
INV2 2 F 30 Investigator Junior X* PPP, AC
INV3 10 M 55 Investigator Senior X* PPP, AC
INV4 13 M 45 Investigator Senior X* PPP, AC
INV5 2 F 30 Investigator Junior X* PPP
INV6 7 M 60 Investigator Senior X* PPP, AC
INV7 10 M 50 Investigator Senior X PPP, AC
INV8 2 M 29 Investigator Junior X PPP, AC
INV9 7 M 35 Investigator Middle X PPP
FW1 13 M 35 Field Worker Senior X PPP
FW2 8 F 35 Field Worker Senior X PPP
FW3 3 M 25 Field Worker Middle X* PPP
X* Quoted in the manuscript.
PPP: public-private partnerships sponsored project (transnational research)
AC: academic research for MRU initiated project
INV: investigator
FW: field worker
Table 2 Topics identified by content analysis and discussed in the manuscript
Framework of clinical research Local contexts of clinical research
Transnational research Characteristics of study participants in Lambaréné
Independent or academic research
Ethical and regulatory guidelines and rules The performativity of relationships and networks of research participants. Patient-physician relationships
Patient-physician relationships
Participant- investigator relationships
Access to health care as “performative” tool for research purposes
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demic research have been poorly discussed during our
interviews; however, investigators did not claim the inde-
pendence of their own studies over transnational projects.
The study protocol design and the informed consent pro-
cess are carried out with similar standards, guidelines and
procedures for transnational and academic researches.
Guidelines and rules: Ethical and regulatory standards
The International Conference on Harmonization
between the regulatory authorities of EU, Japan and
USA with pharmaceutical companies has provided the
main guidelines for conducting clinical trials around the
world. The so-called Good Clinical Practice (ICH-GCP)
have been referenced by the MRU’s investigators as the
main guidelines for performing their activities, although
the guidelines of the Council of International Organiza-
tions for Medical Sciences (CIOMS) have also been
mentioned as dedicated to ethical considerations specific
to developing countries. GCP guidelines are considered
as the document: “that allows us to claim that we per-
form as elsewhere although environmental and cultural
contexts may generate slight differences”.
The coherence between international standards and the
national ethical and regulatory framework is perceived as
an essential objective on the way to performing valuable
science: “The ICH-GCP has identified the stakeholders of
research and their individual responsibilities”.
“A similar approach should be implemented for our
national regulations because research should follow
the rules within a country”. As noticed by a senior
investigator, the other regions worldwide like Europe
“have a special bureau for the regulation of clinical
trials activities and drug registration”. In Africa, bio-
medical research makes way for regulations which
are however being performed according to the fol-
lowing claim of an interviewee: “Local and interna-
tional regulations should be harmonized to conduct
r e s e a r c h .A l t h o u g hi ti sal o n gj o u r n e y ,G a b o ni s
working to build up ethical and regulatory systems
for the management of biomedical research”.
The process of informed consent has been identified
as the main procedure linking international require-
ments and local contexts for the purpose of conducting
research of high standards.
“The informed consent process would be perceived
as a means and strategy which allow a volunteer to
be an active participant and to participate in the
best way possible”.
This view of a senior researcher at the MRU points to
the challenges in applying ethical principles to the daily
practice in a particular social and economic context.
The process of informed consent is based on the widely
shared idea to protect the freedom, safety and well-
being of human participants during the experimental
process: “Over the last 15 years at the MRU, informed
consent has been always obtained before any research
onset, but now the compliance to the ethical committee
requirements is better, although informed consent forms
moved from 2 pages to around 10 pages”.
The requirements of ethical guidelines and regulatory
authorities make some aspects of the informed consent
form (ICF) difficult for both investigators and partici-
pants. A field worker and investigator have focused on a
particular word that makes the process difficult. “Experi-
mental” is a word that scares people and generates mis-
conceptions. On the other hand, it is not possible to
avoid this word because of ethical and regulatory
requirements; it is perceived as an intention to hide the
fact that research is an experiment and different from
medical care. However, the requirement of informed
consent should not necessarily be perceived as conflict-
ing with views from the stakeholders involving: “Regula-
tory and ethical sides are overseers; the most active are
investigators and participants. Their interactions and
relationships in the process would reflect the best possi-
ble, the need to have an informed person about the pur-
poses of a proposed research as well as implications
before participation”.
There is a variety of additional tools and strategies for
researchers to deliver the best informed consent to their
potential participants, including a community based
team, public communication, and concise summaries of
the ICFs-leaflets used for the purpose of informing and
involving participants actively in the best possible way.
Local contexts and clinical research: Research activities
and their impact on community participation
Characteristics of research participants in Lambaréné
Freedom and willingness of members of the local commu-
nity to participate in research have to emerge from scienti-
fic, social, economic and other determinants according to
ethical principles as well as from the claims and attitudes
of research stakeholders, including researchers at the
MRU. A variety of determinants such as lack of education,
low income, high disease burden, and limited access to
health care has been identified as major factors that influ-
ence the community members to enroll in experimental
procedures in Lambaréné by the interviewees. Social
classes are a possiblee x p l a n a t i o nf o rt h e“easiest enrol-
ment” of rural people and economically disadvantaged city
dwellers in research. In contrast, middle classes and edu-
cated people express more criticism of and reluctance
towards research and even medical practices. However,
our interviewees had conflicting opinions about the
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participants.
Social relationships and networks are either the main or
the secondary reason for participating in research in
Lambaréné according to our interviewees. In this rela-
tional system, participation is influenced by relatives,
neighbours, the experience made by other research partici-
pants as well as the research team. Finally, many research-
ers have speculated on resources such as the type of
communication, access and quality of health care and the
role of the relationships and social networks as essential
factors in characterizing the research participants in
Lambaréné.
Relationships and social networks of research participants:
Means to perform the social perception of clinical research
Attempts to summarize the characteristics of research par-
ticipants and to emphasize the ethical concerns these
characteristics generate may lead to the following assump-
tion: in social and economic contexts of sub-Saharan
Africa, like Lambaréné, both investigators and participants
overstate the patient-physician relationship and enter into
the experimental process with misconceptions and misuse
of participant-investigator requirements. However,
poverty, high burden of diseases, and the lack of or limited
access to health care as essential drivers are not yet con-
sidered to be isolated motivations for individuals to parti-
cipate in research. From the investigator’s point of view, it
is therefore essential to understand the value of a process
such as that of informed consent procedure. Is it not just
an inoperative process and merely a formality? For all
interviewees, the social networks of research participants
exist and may be impacted with variable resources such as
human interactions, relationships, style of communication,
type of study documentation, and access to health system.
Relatives, neighbours, and other participants are also iden-
tified as important drivers for research participation, but
interactions and relationships with the research teams,
institution and participation in experimental procedures
seem to be the more powerful tools that allow for the
emergence of “informed, voluntary and less determined
participants”. Therefore, there is for most of our intervie-
wees an advantage of conducting research in Lambaréné
because the research purposes are shared and better
understood than in other cities of Gabon, like “Libreville,
Mouila”, where no or limited research activities are carried
out.
Patient-physician interactions and relationships in the
process of participation in research
Availability and access to health care is an essential fac-
tor of conducting clinical research in Lambaréné. Health
care has been perceived as the central resource and
exchangeable good that supports a kind of deal between
a participant in need and a researcher who wants to
collect data for scientific purposes. Such a deal occurs
during interactions in which each party has declared in
written form that the entire process is based on the
informed consent of the participant. Basically, if infor-
mation is shared properly, the deal is acceptable. How-
ever, there are several factors that may make it harmful.
First, the clinical researcher who collects data for scien-
tific purposes is often a physician or nurse seen as care-
giver by the participant. There is a continuum of roles
and a difficulty to perceive the dividing line between
research and routine care procedures for the partici-
pants. The burden of diseases and economic constraints
influence this perception and the mix-up of research
procedures with health care. The issues related to the
“deal” have been identified as a major cause of poor-
quality science due to the high rate of lack of compli-
ance and withdrawal during the course of the study. On
the other hand health-care provision during research on
the participants has been perceived as a resource
embedded in other resources that sustain the establish-
ment of long term relationships between the research
institution and the community. From this perspective,
there is no exchange restricted to one item and limited
in time. Access to highly qualified health care is pro-
moted, and some researchers consider the research pur-
poses as a continuum of that global health objective.
Participant-investigator relationships
The rate of people living in Lambaréné and vicinities with
a positive view of the MRU and its research activities vary
from 40% to 90% according to some interviewees who
were asked to provide such estimation. Several reasons
may support this broad range. For example, a wide variety
of different studies are conducted at the MRU such as
Phase I to Phase IV clinical trials, which assess the safety
and efficacy of interventions, such as drugs and vaccines.
Invasive procedures such as multiple blood sampling and
bone marrow sampling are also performed.
T h ea t t i t u d et o w a r d sr e s e a r c hm a ya l s ob ei n f l u e n c e d
by the specific objectives and procedures of a study. Refu-
sal rate in the same area for the same interventional trial
differ significantly in two age categories. For example,
parents are reluctant to enroll infants in trials, whereas
they have fewer reservations about enrolling older kids.
Participation and withdrawal of consent rates have differ-
ent patterns in the same village for two different trials
with different goals and procedures. In a vaccine trial,
pressure on the research team to address safety concerns
may vary significantly as the trial progresses. At the
beginning, the rate of unexpected visits after drug or vac-
cine administration seems higher than during the course
or at the end of the trial. All these cases where suggested
by our interviewees as common features of the partici-
pants’ endeavours related to study specific procedures.
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This study reports the current patterns of clinical
research activities including the framework structure and
the contexts in which activities evolve in a sub-Saharan
African center from the perspective of its key scientists
and workers. Transnational research carried out through
collaborations with mainly Western partners and locally
initiated academic studies se e mt ob ed i s t i n c tt y p e so f
research conducted at the MRU in Lambaréné, Gabon.
In transnational collaborations, from the perspective of
the core-periphery model, the scientists at the MRU may
be considered as the “field workers” who collect data fol-
lowing the study protocol design and implementation by
Western partners [9]. Additionally, the latter take care of
the more complicated and demanding tasks such as
managing the technical and financial side of the study
and monitoring the study procedures to ensure the qual-
ity of the scientific production. Because Western partners
provide outstanding scientific institutions and scientists
as well as technology and financial resources, the main
contents and models of scientific activities are elaborated
predominantly by them. Thus, studies carried out in
Africa may be late stage or confirmatory steps and not
directly linked to local economic and social demands. For
instance, applications of models elaborated by Western
scientists and institutions on the biology and immunol-
ogy of the malaria parasite in Lambaréné are likely to
generate confirmatory data. Such research may be of lim-
ited value to the research center itself, which does not
necessarily develop the ability to generate the models and
is unlikely to stimulate innovation for economic and
social development [6].
Objections may point to the above as a simplistic and
partial interpretation of the perceptions of MRU research-
ers considering the development of clinical research in
sub-Saharan Africa over the last decade. Beyond a rigid
labour division of central versus peripheral activities, mul-
tinational trials can be considered as social organizations
that involve human and non- human components with
the ultimate goal of scientific production. From this per-
spective, there may be an opportunity for actors to impact
both the natural course of relationships and the scientific
contents and surrounding contexts of research activities.
As part of multinational research, international ethical
and regulatory standards have been described by our inter-
viewees as means to perform research as elsewhere, i.e. to
requirements for generation of accurate and reliable scien-
tific information. Even though there is similarity in scienti-
fic content, as it is set up in Western countries and can be
applied in Africa, ethical and regulatory rules and pro-
cesses are being dynamically implemented with regard to
economic, social and cultural contexts with the ultimate
goal of conducting high-quality research in Lambaréné.
The local community’s perception of research activities
may be reduced to a less biased perception through daily
interaction and consistent relationships with the research
team, as attested by a possible emergence of participant-
investigator relationships in our study setting and else-
where [9-11].
Academic or ancillary studies are locally designed and
conducted by MRU researchers. This type of research may
be considered as an initiative to impact the course of the
core-periphery relationships leading to scientific research
and output that conform to the local long-term economic
and social demands. Therefore, implementing interna-
tional rules and guidelines while taking into account the
local contexts as well as the scientific initiatives of local
researchers may contribute to the emergence of biomedi-
cal institutions and scientists those activities may be more
situated by the requirements and benefit of their local con-
texts. However, the production of science at the MRU has
not been shown by researchers to be a dichotomous pro-
cess of transnational versus local academic research.
On the contrary, locally initiated studies are sometimes
ancillary to transnational projects. This suggests that
although transnational research may potentially reproduce
the core-periphery model, it can also sustain the produc-
tion and emergence of institutions and scientists in a
peripheral region, like sub-Saharan Africa, with their own
structure of centralization.
The recent development of public-private partnerships
for research in sub-Saharan Africa in the context of mil-
lennium challenges and the existence of several biomedical
research groups in sub-Saharan Africa countries is a new
historical context. Here, we are reporting the patterns of
research activities in a particular sub-Saharan research
institution, namely the Medical Research Unit of Albert
Schweitzer Hospital located in Lambaréné, Gabon. From
the perspective of the MRU’s researchers, transnational
collaboration with outstanding Western institutions and
scientists could limit the sub-Saharan science to subsidiary
and confirmatory activities. However, this transnational
collaboration, which implies scientific contents and ethical
and regulatory rules, allows sub-Saharan scientists to per-
form more dynamically situated research and simulta-
neously impact the local community, its perception of
research activities as well as the scientific contents with
the potential of positively impacting the economic and
social development in the future.
Limiting empirical material to the perceptions of the
core researchers and workers at the MRU may be consid-
ered a weakness of this paper, seeing as though a single
and unique conclusion and statement would be difficult.
However, this study has made an important contribution
to illuminating the complex and deep patterns of scienti-
fic activities and social contexts in sub-Saharan Africa
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tion. Importantly, the generation of interesting future
research questions is also an important outcome of this
study. So far social sciences have mainly assessed the
impact and benefit of global interventions on the health-
care systems in sub-Saharan Africa and the quantitative
patterns of biomedical publications of the African scien-
tists. This study points out the need for additional ques-
tions concerning the contents of scientific production as
well as their links and potential impact on the long-term
economic and social development in sub-Saharan Africa.
To do so, we assume the posture, based on our finding,
which an integrative approach would focus on specific
questions to understand the dynamics of building-up the
research institutions, the changes, if any on the elabora-
tion on scientific contents considering the surrounding
local economic, social and cultural needs. The methodo-
logical implications of such a project would be similar to
the scientific frame at the Kenya Medical Research Insti-
tute, which considers the ethics of biomedical research in
the contexts of sub-Saharan Africa and transnational
research as a central process for the acceptability and
validity of the global scientific enterprise in poor commu-
nities. More social science studies, research teams, and
projects located within the clinical research site learning
from the daily interactions with the scientists when they
doing science [10-12] are needed. Additionally, as sug-
gested by our findings, social and human activities as
well as organizations are embedded, which allows one to
assume that they should be studied using the paradigm
that they affect each other in a dynamic manner [13,14].
Conclusion
Future research questions including, but not limited to,
interactions between transnational and locally designed
studies, the impact of ethical and regulatory processes
on the contents and the quality of the data generated,
emergence of biomedical research structures like MRU
and their networks through the study of individual
scientists trajectories, the emergence of research partici-
pants and the interrelationships of biomedical research
and public health would be essential for understanding
the contribution of sub-Saharan African regions to
scientific production.
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